title: Omission of extended spectrum β lactamases detection: are the new Clinical Laboratory Standards Institute guidelines misleading?
authors: C
authors: C
authors: Chande
authors: S
authors: S
authors: Makhija
authors: S
authors: S
authors: Lilani
authors: R
authors: R
authors: Shirpurkar
authors: P
authors: P
authors: Veer
authors: A
authors: A
authors: Chivate
authors: P
authors: P
authors: Patekar
authors: A
authors: A
authors: Joshi
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects* / Q000201:enzymology; D001424:Bacterial Infections / Q000175:diagnosis / Q000382:microbiology; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000592:standards*; D017410:Practice Guidelines as Topic; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000378:metabolism*; D047090:beta-Lactams / Q000494:pharmacology*
chemical_list: D000900:Anti-Bacterial Agents; D047090:beta-Lactams; D001618:beta-Lactamases